Skip to main content

Get out your Red Bulls and 80s hair metal wigs, because Philadelphia's favorite lefty relief wildcard is back... nd so too is the the Philadelphia Phillies most consistent reliever since 2020.

The Phillies recalled Jojo Romero and Connor Brogdon from the 60-day IL and COVID-related IL respectively Friday afternoon.

Romero had season ending Tommy John surgery in May of 2021 after posting a lackluster 7.00 ERA over nine innings. Expectations had been high for the young lefty following a promising start to the 2020 season in which he held a 2.89 ERA through his first career 9.1 innings until back-to-back disaster outings forced his ERA to 7.59 by season's end.

Also debuting during 2020's shortened season was Connor Brogdon who had a nearly antithetical rookie season. Though his career began poorly, surrendering a home run to the first Major League hitter he faced, Brogdon has only charged uphill since, sporting a 3.22 career ERA over 86.2 innings pitched.

He's a very necessary addition to the back end of the Phillies bullpen.

Making way for Brogdon and Romero are lefty Cristopher Sánchez and infielder Will Toffey, who unfortunately never got to make his big league debut. Making room on the 40-man roster for Romero was Hans Crouse who was recalled, then subsequently placed on the 60-day IL.

More From SI's Inside The Phillies:

  1. How Mike Trout Will Join the Phillies
  2. Have the Philadelphia Phillies Found Their Centerfielder of the Future?
  3. Andrew Painter is Off to a Historic Start
  4. Could The Phillies Soon Be Playing in Wawa Park?
  5. 18-Year-Old Phillies Prospect is Making History
  6. How did Philadelphia end up with Citizens Bank Park?
  7. How the Phillie Phanatic Came to be America's Favorite Sports Mascot
  8. This Unlikely Draft Pick Could be the Final Piece in the Phillies Next Blockbuster Trade
  9. Picking the Phillies' All-Time Single Season Lineup
  10. Drawing Comparisons to Harper, Phillies Prospect Wilson is Heating Up

Make sure to follow Inside the Phillies on Substack and Twitter!